Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 405Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Exjade

02 6Exjade/Jadenu

PharmaCompass

01

Brand Name : Exjade/Jadenu

Deferasirox

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Exjade/Jadenu

arrow
The Pharmacy Technology
Not Confirmed

Deferasirox

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 653

2019 Revenue in Millions : 975

Growth (%) : -33

blank

02

Brand Name : Exjade/Jadenu

Deferasirox

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Exjade/Jadenu

arrow
The Pharmacy Technology
Not Confirmed

Deferasirox

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 563

2020 Revenue in Millions : 653

Growth (%) : -14

blank

03

Brand Name : Exjade/Jadenu

Deferasirox

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Exjade/Jadenu

arrow
The Pharmacy Technology
Not Confirmed

Deferasirox

Main Therapeutic Indication : Hematology

Currency : USD

2022 Revenue in Millions : 323

2021 Revenue in Millions : 563

Growth (%) : -43

blank

04

Brand Name : Exjade

Deferasirox

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Exjade

arrow
The Pharmacy Technology
Not Confirmed

Deferasirox

Main Therapeutic Indication : Blood Related Disorders

Currency : USD

2014 Revenue in Millions : 3.70%

2013 Revenue in Millions :

Growth (%) :

blank

05

Brand Name : Exjade

Deferasirox

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Exjade

arrow
The Pharmacy Technology
Not Confirmed

Deferasirox

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 926

2014 Revenue in Millions : 917

Growth (%) : -1%

blank

06

Brand Name : Exjade

Deferasirox

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Exjade

arrow
The Pharmacy Technology
Not Confirmed

Deferasirox

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 956

2015 Revenue in Millions : 917

Growth (%) : 4

blank

07

Brand Name : Exjade/Jadenu

Deferasirox

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Exjade/Jadenu

arrow
The Pharmacy Technology
Not Confirmed

Deferasirox

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 1,059

2016 Revenue in Millions : 956

Growth (%) : 11

blank

08

Brand Name : Exjade/Jadenu

Deferasirox

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Exjade/Jadenu

arrow
The Pharmacy Technology
Not Confirmed

Deferasirox

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 1,099

2017 Revenue in Millions : 1,059

Growth (%) : 4%

blank

09

Brand Name : Exjade/Jadenu

Deferasirox

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Exjade/Jadenu

arrow
The Pharmacy Technology
Not Confirmed

Deferasirox

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 975

2018 Revenue in Millions : 1,099

Growth (%) : -11

blank